PUBLICATIONS

2017

Shapiro et al. A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening. Am J Gastroenterol advance online publication, 10 October 2017; doi: 10.1038/ajg.2017.285

Murray et al. Validation of a Circulating Tumor-Derived DNA Blood Test for Detection of Methylated BCAT1 and IKZF1 DNA. JALM 2017, doi: 10.1373/jalm.2017.023135

2014

Mitchell et al. A Panel of Genes Methylated with High Frequency in Colorectal Cancer. BMC Cancer. 2014;14:54.

Pedersen et al. CAHM, a Long Non-Coding RNA Gene Hypermethylated in Colorectal Neoplasia.Epigenetics. 2014 Aug;9(8):1071-82.

2012

Collins et al. Screening for Colorectal Cancer and Advanced Colorectal Neoplasia in Kidney Transplant Recipients: Cross Sectional Prevalence and Diagnostic Accuracy Study of Fecal Immunochemical Testing for Hemoglobin and Colonoscopy. BMJ. 2012 Jul 25;345:e4657.

LaPointe et al. Discovery and Validation of Molecular Biomarkers for Colorectal Adenomas and Cancer with Application to Blood Testing. PLoS One. 2012;7(1):e29059.

2011

Graham et al. Colorectal Neoplasia Differentially Expressed (CRNDE), a Novel Gene with Elevated Expression in Colorectal Adenomas and Adenocarcinomas. Genes Cancer. 2011 Aug;2(8):829-40.

2008

LaPointe et al. Map of Differential Transcript Expression in the Normal Human Large Intestine. Physiol Genomics. 2008 Mar 14;33(1):50-64.

2006

Smith et al. Comparison of a Brush-Sampling Fecal Immunochemical Test for Hemoglobin with a Sensitive Guaiac-Based Fecal Occult Blood Test in Detection of Colorectal Neoplasia. Cancer. 2006 Nov 1;107(9):2152-9.

2003

Young et al. Prescreening Evaluation of a Brush-Based Fecal Immunochemical Test for Hemoglobin. J Med Screen. 2003;10(3):123-8.

Cole et al. A Randomised Trial of the Impact of New Fecal Hemoglobin Test Technologies on Population Participation in Screening for Colorectal Cancer. J Med Screen. 2003;10(3):117-22.

Social Icons

Facebook Twitter LinkedIn